Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity

被引:36
作者
Boldrup, Linda [1 ]
Coates, Philip J. [2 ]
Laurell, Goran [3 ]
Nylander, Karin [1 ]
机构
[1] Umea Univ, Dept Med Biosci Pathol, SE-90185 Umea, Sweden
[2] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Tayside Tissue Bank, Dundee DD1 9SY, Scotland
[3] Umea Univ, Dept Clin Sci ENT, SE-90185 Umea, Sweden
关键词
p63; SCCHN; Sub-site; Oral cavity; Tongue; Gingiva; SQUAMOUS-CELL CARCINOMA; ISOFORM EXPRESSION; P53; HOMOLOG; NECK; HEAD; SURVIVAL; CANCER; TISSUE; LIMB; GENE;
D O I
10.1016/j.oraloncology.2011.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Squamous cell carcinoma of the head and neck, SCCHN, the sixth most common cancer in the world, comprises tumours of different anatomical sites. The overall survival is low, and there are no good prognostic or predictive markers available. The p53 homologue, p63, plays an important role in development of epithelial structures and has also been suggested to be involved in development of SCCHN. However, most studies on p63 in SCCHN have not taken into account the fact that this group of tumours is heterogeneous in terms of the particular site of origin of the cancer. Mapping and comparing p63 expression levels in tumours and corresponding clinically normal tissue in SCCHN from gingiva, tongue and tongue/floor of the mouth revealed clear differences between these regions. In normal samples from tongue and gingiva, tongue samples showed 2.5-fold higher median p63 expression and also more widespread expression compared to gingival samples. These results emphasise the importance of taking sub-site within the oral cavity into consideration in analyses of SCCHN. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:861 / 865
页数:5
相关论文
共 20 条
[1]  
BLOT WJ, 1988, CANCER RES, V48, P3282
[2]  
Boldrup L, 2005, INT J ONCOL, V27, P1661
[3]   Association between High miR-211 microRNA Expression and the Poor Prognosis of Oral Carcinoma [J].
Chang, K.-W. ;
Liu, C. J. ;
Chu, T.-H. ;
Cheng, H.-W. ;
Hung, P. S. ;
Hu, W. Y. ;
Lin, S. C. .
JOURNAL OF DENTAL RESEARCH, 2008, 87 (11) :1063-1068
[4]   TAp63 induces senescence and suppresses tumorigenesis in vivo [J].
Guo, Xuecui ;
Keyes, William M. ;
Papazoglu, Cristian ;
Zuber, Johannes ;
Li, Wangzhi ;
Lowe, Scott W. ;
Vogel, Hannes ;
Mills, Alea A. .
NATURE CELL BIOLOGY, 2009, 11 (12) :1451-U150
[5]   AIS is an oncogene amplified in squamous cell carcinoma [J].
Hibi, K ;
Trink, B ;
Patturajan, M ;
Westra, WH ;
Caballero, OL ;
Hill, DE ;
Ratovitski, EA ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5462-5467
[6]   Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy [J].
Huang, Tai-Lin ;
Tsai, Wen-Ling ;
Chien, Chih-Yen ;
Lee, Tsair-Fwu ;
Fang, Fu-Min .
QUALITY OF LIFE RESEARCH, 2010, 19 (09) :1243-1254
[7]  
Krstevska V, 2010, J BUON, V15, P690
[8]   The role of human papillomavirus in head and neck cancer [J].
Lajer, Christel Braemer ;
Von Buchwald, Christian .
APMIS, 2010, 118 (6-7) :510-519
[9]   Retrospective study of survival and treatment pattern in a cohort of patients with oral and oropharyngeal tongue cancers from 1987 to 2004 [J].
Lam, Lisetta ;
Logan, Richard M. ;
Luke, Colin ;
Rees, Guy L. .
ORAL ONCOLOGY, 2007, 43 (02) :150-158
[10]   p63 is a p53 homologue required for limb and epidermal morphogenesis [J].
Mills, AA ;
Zheng, BH ;
Wang, XJ ;
Vogel, H ;
Roop, DR ;
Bradley, A .
NATURE, 1999, 398 (6729) :708-713